(S (NP-SBJ (NP (JJ Stable) (NN expression)) (PP (IN of) (NP (NP (NN HB24)) (, ,) (NP (DT a) (JJ diverged) (JJ human) (NN homeobox) (NN gene)) (, ,))) (PP (IN in) (NP (NN T) (NNS lymphocytes)))) (VP (VBZ induces) (NP (NP (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN T) (NN cell) (NP-COOD (NP (NN activation)) (CC and) (NP (NN growth)))))))) (. .))
(S (NP-SBJ-53 (NP (NP (DT A) (JJ diverged) (NN homeobox) (NN gene)) (, ,) (NP (NN HB24))) (, ,) (SBAR (WHNP-54 (WDT which)) (S (NP-SBJ-55 (-NONE- *T*-54)) (VP (VBZ is) (VP (VBN known) (S (NP-SBJ-56 (-NONE- *-55)) (VP (TO to) (VP (VB be) (VP (VBN induced) (NP (-NONE- *-56)) (PP-TMP (VBG following) (NP (NN lymphocyte) (NN activation))))))))))) (, ,)) (VP (VBD was) (VP (VBN introduced) (NP (-NONE- *-53)) (PP (IN into) (NP (NN Jurkat) (NN T) (NNS cells))) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT a) (JJ constitutive) (NN promoter))))))) (. .))
(S (NP-SBJ-57 (NP (JJ Stable) (NNS transfectants)) (PP (IN of) (NP (NN HB24))) (SBAR (-NONE- *ICH*-58))) (VP (VBD were) (VP (VBN established) (NP (-NONE- *-57)) (SBAR-58 (WHNP-59 (WDT that)) (S (NP-SBJ (-NONE- *T*-59)) (VP-COOD (VP (VBD expressed) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN HB24) (NN mRNA))))) (CC and) (VP (VBD possessed) (NP (NP (DT an) (JJ altered) (NN phenotype)) (ADJP (JJ suggestive) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells))))))))))) (. .))
(S (NP-SBJ-60 (NP (DT A) (NN number)) (PP (IN of) (NP (NP (NNS genes)) (VP-COOD (VP (VBN known) (S (NP-SBJ-62 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN induced) (NP (-NONE- *-62)) (PP-TMP (VBG following) (NP (NN T) (NN cell) (NN activation)))))))) (CC and) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN cell) (NN growth)))))))) (VP (VBD were) (VP (VBN increased) (NP (-NONE- *-60)) (PP (IN in) (NP (NP (DT the) (NNS transfectants)) (, ,) (PP (VBG including) (NP-COOD (NP (NN c-fos)) (, ,) (NP (NN c-myc)) (, ,) (NP (NN c-myb)) (, ,) (NP (NN HLA-DR)) (, ,) (NP (NN lck)) (, ,) (NP (NN NF-kappa) (NN B)) (, ,) (NP (NN interleukin-2)) (CC and) (NP (NP (NN interleukin-2) (NN receptor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-))))))))) (. .))
(S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (NP (NN IL-2R) (NN alpha) (NN expression)) (PP (IN by) (NP (NP (JJ transient) (NN transfection)) (PP (IN of) (NP (NN IL-2R) (NN alpha) (NN promoter) (NNS constructs))) (PP (IN into) (NP (DT the) (NN HB24) (NNS transfectants)))))))) (VP (VBD revealed) (NP (NP (NP (JJ constitutive) (NN expression)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (QP (RB about) (CD 60)) (NN %)) (PP (IN of) (NP (ADJP-COOD (ADJP (NP (NN phytohemagglutinin-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (NN phorbol) (JJ ester-activated))) (NN Jurkat) (NNS cells))))) (-RRB- -RRB-))) (SBAR (WHNP-63 (WDT that)) (S (NP-SBJ (-NONE- *T*-63)) (VP (VBD was) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN kappa) (NN B) (NN site)) (PP (IN in) (NP (DT the) (NN IL-2R) (NN alpha) (NN promoter))))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (DT the) (VBN increased) (NN HB24) (NN mRNA) (NNS levels))))) (, ,) (NP-SBJ (DT the) (NN Jurkat) (NN HB24) (NNS transfectants)) (VP (VBD proliferated) (ADVP-TMP (ADVP (RBR more) (RB rapidly)) (PP (IN than) (NP (NN control) (NN cell) (NNS lines))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ-64 (NP (JJ stable) (NN expression)) (PP (IN of) (NP (NN HB24)))) (VP (VBZ confers) (NP (DT an) (NN activation) (NN phenotype)) (PP (IN on) (NP (DT a) (JJ human) (NN T) (NN cell) (NN line))) (, ,) (S (NP-SBJ (-NONE- *-64)) (VP (VBG implicating) (NP (DT this) (NN gene)) (PP (IN as) (NP (NP (DT an) (JJ important) (JJ transcriptional) (NN factor)) (PP-TMP (IN during) (NP (NN T) (NN cell) (NP-COOD (NP (NN activation)) (CC and) (NP (NN growth)))))))))) (. .))
